Visual Outcomes After Implantation of Allogenic Lenticule in a 100-µm Pocket for Moderate to High Hyperopia: 2-Year Results.

Autor: Liu S, Wei R, Choi J, Li M, Zhou X
Jazyk: angličtina
Zdroj: Journal of refractive surgery (Thorofare, N.J. : 1995) [J Refract Surg] 2021 Nov; Vol. 37 (11), pp. 734-740. Date of Electronic Publication: 2021 Nov 01.
DOI: 10.3928/1081597X-20210730-02
Abstrakt: Purpose: To investigate 2-year visual outcomes, stability, and predictability after allogenic lenticule implantation in a 100-µm pocket for moderate to high hyperopia correction.
Methods: In this prospective case series, 14 eyes of 9 patients with moderate to high hyperopia ranging from +3.00 to +8.00 diopters sphere were included between March and September 2018. Allogenic lenticules extracted from myopic small incision lenticule extraction were implanted into a pocket created by femtosecond laser at a 100-µm depth in recipients with hyperopia. All patients were followed up for 2 years. Uncorrected (UDVA) and corrected (CDVA) distance visual acuity, manifest refraction, corneal topography, Fourier-domain optical coherence tomography, and in vivo confocal microscopy were examined.
Results: At postoperative 2 years, 2 eyes (14.3%) gained one line of CDVA, 11 eyes (78.6%) had unchanged CDVA, and 1 eye (7.1%) lost one line of CDVA. No eyes lost two or more lines of CDVA. Twelve of the treated eyes (85.7%) had postoperative uncorrected near visual acuity equal to or better than pre-operative values. The spherical equivalent decreased from +5.53 ± 1.45 D preoperatively to -0.60 ± 1.20 D at postoperative year 2 ( P < .001). The anterior mean keratometric readings increased from 42.41 ± 1.03 D preoperatively to 48.38 ± 1.98 D at postoperative year 2 ( P < .001). Of 14 treated eyes, 10 eyes (71.4%) had spherical equivalent within ±1.00 D.
Conclusions: The findings suggest that allogenic lenticule transplantation may be a promising option for the correction of moderate to high hyperopia. [ J Refract Surg . 2021;37(11):734-740.] .
Databáze: MEDLINE